I

Inno-Gene SA
WSE:IGN

Watchlist Manager
Inno-Gene SA
WSE:IGN
Watchlist
Price: 5.04 PLN -0.4% Market Closed
Market Cap: 17.7m PLN
Have any thoughts about
Inno-Gene SA?
Write Note

Inno-Gene SA
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Inno-Gene SA
Cash from Financing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
I
Inno-Gene SA
WSE:IGN
Cash from Financing Activities
zł895k
CAGR 3-Years
-29%
CAGR 5-Years
38%
CAGR 10-Years
33%
M
Medicofarma Biotech SA
WSE:MDB
Cash from Financing Activities
zł596.7k
CAGR 3-Years
N/A
CAGR 5-Years
127%
CAGR 10-Years
N/A
R
Ryvu Therapeutics SA
WSE:RVU
Cash from Financing Activities
zł91.7m
CAGR 3-Years
N/A
CAGR 5-Years
41%
CAGR 10-Years
26%
S
Selvita SA
WSE:SLV
Cash from Financing Activities
-zł50.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Inno-Gene SA
Glance View

Market Cap
17.7m PLN
Industry
Life Sciences Tools & Services

Inno Gene SA engages in the management of startup biotechnology companies. The company is headquartered in Poznan, Woj. Wielkopolskie. The company went IPO on 2011-02-08. Inno-Gene SA’s portfolio comprises of Centrum Badan DNA Sp. z o.o., a company that provides services in the field of genetic medical diagnostics, including microbiological diagnosis of infection and the suitability of human congenital diseases using tests performed on DNA microarray technology. On March 22, 2013, the Company established a new subsidiary, Centrum Edukacji Bio-Medycznej Sp. z o.o. On April 11, 2013, the Company established two new indirect subsidiaries, Genomix Sp. z o.o. and Madgenetix Sp. z o.o. In addition, it operates through VitainSillica Sp z o o.

IGN Intrinsic Value
2.03 PLN
Overvaluation 60%
Intrinsic Value
Price
I

See Also

What is Inno-Gene SA's Cash from Financing Activities?
Cash from Financing Activities
895k PLN

Based on the financial report for Jun 30, 2024, Inno-Gene SA's Cash from Financing Activities amounts to 895k PLN.

What is Inno-Gene SA's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
33%

Over the last year, the Cash from Financing Activities growth was -72%. The average annual Cash from Financing Activities growth rates for Inno-Gene SA have been -29% over the past three years , 38% over the past five years , and 33% over the past ten years .

Back to Top